Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
bio-11006 | myristoylated alanine-rich c-kinase substrate | NA | Clinical trial target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Chronic Obstructive Airway Disease[MeSHID:D029424] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
63.65 | phase 2 | unknown |
bio-11006 | myristoylated alanine-rich c-kinase substrate | NA | Clinical trial target | TTD , DGIDB | Non-Small Cell Lung Carcinoma[MeSHID:D002289] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
63.65 | phase 2 | unknown |
click here to return to the previous page |